首页> Blood> Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants.

Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants.

导出 LinkOut

翻译打印收藏纠错

第一作者： Ilyas,Chachoua

第一单位： Ludwig Institute for Cancer Research Brussels, Brussels, Belgium; Université Catholique de Louvain and de Duve Institute, Brussels, Belgium;

作者： Ilyas,Chachoua ^[1] ; Christian,Pecquet ^[1] ; Mira,El-Khoury ^[2] ; Harini,Nivarthi ^[3] ; Roxana-Irina,Albu ^[1] ; Caroline,Marty ^[2] ; Vitalina,Gryshkova ^[1] ; Jean-Philippe,Defour ^[1] ; Gaëlle,Vertenoeil ^[1] ; Anna,Ngo ^[4] ; Ann,Koay ^[4] ; Hana,Raslova ^[2] ; Pierre J,Courtoy ^[5] ; Meng Ling,Choong ^[4] ; Isabelle,Plo ^[2] ; William,Vainchenker ^[2] ; Robert,Kralovics ^[3] ; Stefan N,Constantinescu ^[1]

作者单位： Ludwig Institute for Cancer Research Brussels, Brussels, Belgium; Université Catholique de Louvain and de Duve Institute, Brussels, Belgium; ^[1] INSERM, Unité Unité Mixte de Recherche 1170, Institut Gustave Roussy, Villejuif, France; Paris-Saclay, Unité Mixte de Recherche 1170, Institut Gustave Roussy, Villejuif, France; Gustave Roussy, Unité Mixte de Recherche 1170, Villejuif, France; ^[2] CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria; and. ^[3] Experimental Therapeutics Center, Singapore. ^[4] Université Catholique de Louvain and de Duve Institute, Brussels, Belgium; ^[5]